Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Dendritic cells commit T-cells to a tolerant phenotype in tolerant lung transplant recipients

K. Botturi, Y. Lacoeuille, P. Thomas, M. Reynaud-Gaubert, A. Magnan
European Respiratory Review 2008 17: 51-52; DOI: 10.1183/09059180.00010714
K. Botturi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Lacoeuille
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Reynaud-Gaubert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Magnan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Immune characteristics distinguishing tolerant lung transplant recipients (LTR) from patients with Bronchiolitis obliterans syndrome (BOS) are largely unknown. We compared the effect of dendritic cells (DC) on T-cell activation in healthy LTR (non BOS) and in BOS patients.

30 Non BOS and 14 BOS recipients were studied. Mature dendritic cells were derived from blood monocytes and co-cultured with autologous T cells at various ratios. T cell CD69, CD25, CD28, ICOS and CTLA-4 expression and IL-4, IL-13, IFN-γ, and IL-10 production were assessed by flow cytometry. Dendritic cell expression of surface markers and indoleamine 2,3 dioxygenase was also studied. Experiments were repeated in presence of P. aeruginosa or anti-CTLA-4 antibodies.

In dendritic cell/LT co-cultures, T cell CD69, CD28 and ICOS decreased in non BOS (p<0.03). By contrast, CD4+CD25+high T regulatory cells (Treg), CTLA4 expression and IL-10 production increased (p<0.05). Il-13 and IL-4 decreased in non BOS only (p<0.03), whereas IFN-γ did not vary. The increase in dendritic cell/LT ratio induced a decrease in T-cell activation in non BOS, with inverse result in BOS. Compared to BOS, dendritic cells from non BOS displayed a down-modulation of CD83, CD80 and higher levels of IDO (p<0.05). Stimulation by P. aeruginosa did not remove tolerogenic effect of dendritic cells on non BOS T-cells. Finally, decreased Treg and expression of IL-10 were detected when adding anti-CTLA-4 in non BOS (p<0.05) but not in BOS.

In contrast with BOS recipients, dendritic cells from non BOS induce a tolerant T cell phenotype, by using CD80/CD86-CTLA4 axis.

MY JOB AND THE UNIT IN WHICH I WORK

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

I am currently working as a PhD fellow at Antoine Magnan's Laboratory (Equipe d'Accueil 3287, “Environment-related respiratory diseases”) at the Marseille Medical School, Marseille, France. The laboratory is involved in immune studies in humans. It closely collaborates with the chest medicine dept of the University Hospital in Marseille, which has long been recruiting cohorts of patients with chronic bronchial diseases, such as asthma (headed by Professor Daniel Vervloet) and lung chronic rejection (headed by Professor Martine Reynaud-Gaubert and Dr Pascal Thomas).

I began my PhD in 2004, studying the immunological mechanisms leading to chronic lung rejection and asthma, under the supervision of Professor Antoine Magnan. With two papers, including the work presented below, I successfully defended my thesis in November 2007, and qualified as a PhD. I then relocated to the Institut du Thorax in Nantes, where I am currently extending our cohorts to other university hospitals in the frame of multicentric projects.

MY WINNING POSTER AS PART OF MY RESEARCH

The winning abstract covers part of my PhD research, and focuses on immune mechanisms of chronic lung rejection. Chronic lung rejection consists of the occurrence of progressive pulmonary failure due to bronchiolitis obliterans syndrome (BOS), and remains the major cause of long-term lung allograft loss. BOS results from an unclear immune process occurring at some point after surgery, in the absence of donor's immune cells [1]. We hypothesised that the immune characteristics of autologous dendritic cells and their effects on T-cell interactions differ in patients compared with healthy lung transplant recipients. Consecutive lung transplant recipients belonging to the Marseille cohort were recruited. They were routinely investigated with lung function tests and bronchoalveolar lavage, and blood samples were collected at the clinic. Samples were transferred to the laboratory were I perform the following experiments: monocyte isolation, culture and dendritic cell differentiation, T-cell activation studies and cytokine detection at the single cell level, either with or without dendritic cell co-stimulation. The main results indicate that autologous monocyte-derived dendritic cells from healthy recipients differentiate into an immature phenotype, driving T-cells to demonstrate tolerant properties; this occurs as an intrinsic characteristic of the dendritic cells' recipient, which would induce tolerance irrespective of the donor.

MY RESEARCH AS PART OF MY WORKING GROUP/RESEARCH TEAM

This part of my research continued previous works in the field of chronic lung rejection, having demonstrated the compartmentalisation of immune response in transplanted lungs [2] and the importance of T-regulatory (Treg)-cell activation in stable chronic rejection [3].

My research also investigates chronic asthma with the same kind of approach. I developed a model of ex vivo T-cell stimulation with house dust mite-purified allergens and, in this context, studied T-cell activation with regard to T-helper cell (Th) type 1, Th2 and Treg-cell activation. I also monitored the modulation of T-cell co-receptor expression according to the presence of allergy and/or asthma.

THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE

Our results in lung chronic rejection led us to envisage prospective surveys, including a large number of patients, to detect some biological characteristics and features determining the occurrence of BOS. In the future, we will address the following questions. 1) Does T-reg-cell activation predict the stabilisation of BOS? 2) Do the characteristics of dendritic cell–T-cell interactions predict the long-term tolerance of lung transplant?

In the longer term, the rationale for therapeutic interventions, including cellular therapies with T-regulatory cells or immature dendritic cells will be investigated.

Lung Transplantation Best Abstract Award, sponsored by Novartis Pharma Schweiz AG, Roche Pharma AG, Vitrolife Sweden

STATEMENT OF INTEREST

None declared.

    • © ERSJ Ltd

    References

    1. ↵
      Reynaud-Gaubert M. Pathophysiology of obliterative bronchiolitis in lung transplants. Rev Mal Respir 2003; 20: 224–232.
      OpenUrlPubMed
    2. ↵
      Mamessier E, Milhe F, Badier M, Thomas P, Magnan A, Reynaud-Gaubert M. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. J Heart Lung Transplant 2006; 25: 523–532.
      OpenUrlCrossRefPubMed
    3. ↵
      Mamessier E, Lorec A, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M. T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 2007; 84: 908–916.
      OpenUrlPubMed
    PreviousNext
    Back to top
    View this article with LENS
    Vol 17 Issue 107 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Dendritic cells commit T-cells to a tolerant phenotype in tolerant lung transplant recipients
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Dendritic cells commit T-cells to a tolerant phenotype in tolerant lung transplant recipients
    K. Botturi, Y. Lacoeuille, P. Thomas, M. Reynaud-Gaubert, A. Magnan
    European Respiratory Review Apr 2008, 17 (107) 51-52; DOI: 10.1183/09059180.00010714

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Dendritic cells commit T-cells to a tolerant phenotype in tolerant lung transplant recipients
    K. Botturi, Y. Lacoeuille, P. Thomas, M. Reynaud-Gaubert, A. Magnan
    European Respiratory Review Apr 2008, 17 (107) 51-52; DOI: 10.1183/09059180.00010714
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • MY JOB AND THE UNIT IN WHICH I WORK
      • MY WINNING POSTER AS PART OF MY RESEARCH
      • MY RESEARCH AS PART OF MY WORKING GROUP/RESEARCH TEAM
      • THE IMPACT OF MY WORK ON CLINICAL OR RESEARCH PRACTICE
      • STATEMENT OF INTEREST
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Smoking and impact on health
    • Nonpharmacological smoking cessation interventions in clinical practice
    • Pharmacological treatments for tobacco dependence
    Show more Original Articles

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2023 by the European Respiratory Society